C
CardioMech
Developing a catheter-based mitral valve repair technology designed to treat patients suffering from symptomatic DMR
About CardioMech
CardioMech AS is a medical device company developing a catheter-based technology for treating mitral regurgitation, a condition where the mitral valve of the heart doesn't close properly.
Read full description
The company's key technology is a transcatheter-based artificial chordae delivery system. This approach is designed to be a less invasive alternative to open-heart surgery, which is the current standard of care but is often too high-risk for many patients. The device is guided through blood vessels to the heart, where it implants an artificial chord to repair the dysfunctional valve, aiming to reduce or eliminate the regurgitation.
The primary market for CardioMech is patients with degenerative mitral regurgitation who are symptomatic and considered high-risk for conventional surgery. The business model centers on the development, manufacturing, and sale of this specialized medical device to hospitals and cardiac centers that perform structural heart procedures. Revenue will be generated from the sale of the device itself.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Trondheim, Norway
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 75.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Catheters, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning CardioMech.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Dec 2023 | $13M | — | Undisclosed | ↗ |
| DEBT✓Debt | Feb 2023 | $4.5M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for CardioMech is 440 monthly website visits, up 1366.7% over the last three months. CardioMech's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Hadean Ventures
Investinor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CardioMech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardioMech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.